Advertisement
YOU ARE HERE: LAT HomeCollectionsEdwards Lifescience Corp
IN THE NEWS

Edwards Lifescience Corp

FEATURED ARTICLES
BUSINESS
January 24, 2001 | Dow Jones
Edwards Lifesciences Corp. said it is realigning its organization in an effort to spur growth. The Irvine company, which makes products to treat cardiovascular disease, also said it remains "comfortable" with analysts' per-share earnings expectations for last year and 2001. A First Call/Thomson Financial survey of nine analysts produced a mean earnings estimate of 81 cents a share for the company in 2000, and 97 cents a share in 2001.
ARTICLES BY DATE
BUSINESS
April 27, 2001
The Irvine provider of products and services to treat cardiovascular disease said net income for the first quarter was $14.2 million, or 24 cents a share, which excluded a $1.5 million reduction from an accounting change. A year ago, the company's pro forma net income totaled $9.1 million, or 16 cents a share, which excluded nonrecurring expenses. Sales dropped 3% to $191.9 million. The company was spun off last April from Baxter International Inc.
Los Angeles Times Articles
|